Methods and compositions for inducing tumor-specific cytotoxicity
AssigneeYissum Research Development Company of the Hebrew University of Jerusalem
InventorsAbraham Hochberg, Suhail Ayesh
Life of this patent
Estimating the term…
Abstract
The present invention relates to the tumor-specific expression of heterologous polynucleotides, particularly genes encoding cytotoxic products, under the control of transcriptional regulatory sequences. Particularly preferred transcriptional regulatory sequences comprise H19, IGF-1 and IGF-2 P4 transcriptional regulatory sequences, and variants thereof. The present invention also provides expression constructs and methods of administering such expression constructs. The compositions and methods of the invention are useful for the treatment of proliferative disorders, particularly cancer.
Claims35
A method for treating or preventing cancer, comprising administering to a subject in need thereof an effective amount of a vector comprising a heterologous polynucleotide operably linked to one or more regulatory sequences, wherein the regulatory sequence is derived from an H19, IGF-1 or IGF-2 P4 transcriptional regulatory sequence.
A method for reducing cell growth comprising contacting a cancer cell with an effective amount of a vector comprising a heterologous polynucleotide operably linked to one or more regulatory sequences, wherein the regulatory sequence is derived from an H19, IGF-1 or IGF-2 P4 transcriptional regulatory sequence.
A method for treating or preventing cancer, comprising administering to a subject in need thereof an effective amount of a replicative virus, wherein the replicative virus comprises a polynucleotide operably linked to one or more regulatory sequences, wherein the regulatory sequence is derived from an H19, IGF-1 or IGF-2 P4 transcriptional regulatory sequence, and wherein the polynucleotide comprises a sequence encoding a product essential for viral replication.
A method for reducing cell growth comprising contacting a cancer cell with an effective amount of a replicative virus, wherein the replicative virus comprises a polynucleotide operably linked to one or more regulatory sequences, wherein the regulatory sequence is derived from an H19, IGF-1 or IGF-2 P4 transcriptional regulatory sequence, and wherein the polynucleotide comprises a sequence encoding a product essential for viral replication.
A pharmaceutical composition comprising an effective amount of a vector comprising a heterologous polynucleotide operably linked to one or more regulatory sequences, wherein the heterologous polynucleotide comprises a sequence encoding a cytotoxic or cytostatic product, and wherein the regulatory sequence is derived from an H19, IGF-1 or IGF-2 P4 transcriptional regulatory sequence.
A pharmaceutical composition comprising an effective amount of a vector comprising (a) a heterologous polynucleotide operably linked to one or more regulatory sequences, wherein the heterologous polynucleotide comprises a sequence encoding a cytotoxic or cytostatic product, and wherein the regulatory sequence is derived from an H19, IGF-1 or IGF-2 P4 transcriptional regulatory sequence;
- and (b) another therapeutic agent.
A pharmaceutical composition comprising an effective amount of a replicative virus comprising a polynucleotide operably linked to one or more regulatory sequences, wherein the polynucleotide comprises a sequence encoding a product essential for viral replication, and wherein the regulatory sequence is derived from an H19, IGF-1 or IGF-2 P4 transcriptional regulatory sequence.
A pharmaceutical composition comprising an effective amount of a replicative virus comprising (a) a polynucleotide operably linked to one or more regulatory sequences, wherein the polynucleotide comprises a sequence encoding a product essential for viral replication, and wherein the regulatory sequence is derived from an H19, IGF-1 or IGF-2 P4 transcriptional regulatory sequence;
- and (b) another therapeutic agent.
A method for treating or preventing cancer, comprising administering to a subject in need thereof an effective amount of a vector comprising a heterologous polynucleotide operably linked to one or more regulatory sequences, wherein the heterologous polynucleotide comprises a sequence encoding a cytotoxic or cytostatic product, and wherein the regulatory sequence is derived from a transcriptional regulatory sequence of an imprinted human gene.
A method for treating or preventing cancer, comprising administering into a tumor of a subject in need thereof an effective amount of a vector comprising a heterologous polynucleotide operably linked to one or more regulatory sequences, wherein the heterologous polynucleotide comprises a sequence encoding a cytotoxic or cytostatic product, and wherein the regulatory sequence is derived from a transcriptional regulatory sequence of an imprinted human gene.
A method for reducing cell growth comprising the step of contacting a cell with an effective amount of a vector comprising a heterologous polynucleotide operably linked to one or more regulatory sequences, wherein the heterologous polynucleotide comprises a sequence encoding a cytotoxic or cytostatic product, and wherein the regulatory sequence is derived from a transcriptional regulatory sequence of an imprinted human gene.
A method for treating or preventing cancer, comprising administering to a subject in need thereof an effective amount of a replicative virus comprising a heterologous polynucleotide operably linked to one or more regulatory sequences, wherein the heterologous polynucleotide comprises a sequence encoding a product essential for viral replication, and wherein the regulatory sequence is derived from a transcriptional regulatory sequence of an imprinted human gene.
A method for treating or preventing cancer, comprising administering into a tumor of a subject in need thereof an effective amount of a replicative virus comprising a polynucleotide operably linked to one or more regulatory sequences, wherein the polynucleotide comprises a sequence encoding a product essential for viral replication, wherein the regulatory sequence is derived from a transcriptional regulatory sequence of an imprinted human gene.
A method for reducing cell growth comprising the step of contacting a cancer cell with an effective amount of a replicative virus comprising a polynucleotide operably linked to one or more regulatory sequences, wherein the polynucleotide comprises a sequence encoding a product essential for viral replication, and wherein the regulatory sequence is derived from a transcriptional regulatory sequence of an imprinted human gene.
Dependencies are inferred from the claim text.